{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:08:35Z","timestamp":1793304515621,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31870897"],"award-info":[{"award-number":["31870897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14708-6","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:54:02Z","timestamp":1759229642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["DHX9 as a prognostic biomarker and its biological\u00a0roles in acute myeloid leukemia"],"prefix":"10.1186","volume":"25","author":[{"given":"Yacen","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"14708_CR1","unstructured":"National Institute of Health. Cancer Stat Facts: Leukemia \u2014 Acute Myeloid Leukemia (AML). 2024. [https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html]. Accessed Aug 10, 2024."},{"issue":"12","key":"14708_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867.","journal-title":"Blood"},{"issue":"1","key":"14708_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1023\/b:scam.0000007138.44216.3a","volume":"25","author":"CG Lee","year":"1999","unstructured":"Lee CG, Eki T, Okumura K, Nogami M, Soares Vda C, Murakami Y, Hanaoka F, Hurwitz J. The human RNA helicase A (DDX9) gene maps to the prostate cancer susceptibility locus at chromosome band 1q25 and its pseudogene (DDX9P) to 13q22, respectively. Somat Cell Mol Genet. 1999;25(1):33\u20139. https:\/\/doi.org\/10.1023\/b:scam.0000007138.44216.3a.","journal-title":"Somat Cell Mol Genet"},{"issue":"13","key":"14708_CR4","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1021\/bi00179a016","volume":"33","author":"S Zhang","year":"1994","unstructured":"Zhang S, Grosse F. Nuclear DNA helicase II unwinds both DNA and RNA. Biochemistry. 1994;33(13):3906\u201312. https:\/\/doi.org\/10.1021\/bi00179a016.","journal-title":"Biochemistry"},{"issue":"33","key":"14708_CR5","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1021\/bi100795m","volume":"49","author":"A Jain","year":"2010","unstructured":"Jain A, Bacolla A, Chakraborty P, Grosse F, Vasquez KM. Human DHX9 helicase unwinds triple-helical DNA structures. Biochemistry. 2010;49(33):6992\u20139. https:\/\/doi.org\/10.1021\/bi100795m.","journal-title":"Biochemistry"},{"issue":"22","key":"14708_CR6","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.1093\/nar\/gkt804","volume":"41","author":"A Jain","year":"2013","unstructured":"Jain A, Bacolla A, Del Mundo IM, Zhao J, Wang G, Vasquez KM. DHX9 helicase is involved in preventing genomic instability induced by alternatively structured DNA in human cells. Nucleic Acids Res. 2013;41(22):10345\u201357. https:\/\/doi.org\/10.1093\/nar\/gkt804.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"14708_CR7","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.celrep.2018.04.025","volume":"23","author":"A Cristini","year":"2018","unstructured":"Cristini A, Groh M, Kristiansen MS, Gromak N. RNA\/DNA hybrid interactome identifies DXH9 as a molecular player in transcriptional termination and R-Loop-Associated DNA damage. Cell Rep. 2018;23(6):1891\u2013905. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.025.","journal-title":"Cell Rep"},{"issue":"15","key":"14708_CR8","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1093\/nar\/gkl460","volume":"34","author":"FV Fuller-Pace","year":"2006","unstructured":"Fuller-Pace FV. DExD\/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 2006;34(15):4206\u201315. https:\/\/doi.org\/10.1093\/nar\/gkl460.","journal-title":"Nucleic Acids Res"},{"key":"14708_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev.biophys.37.032807.125908","volume":"37","author":"AM Pyle","year":"2008","unstructured":"Pyle AM. Translocation and unwinding mechanisms of RNA and DNA helicases. Annu Rev Biophys. 2008;37:317\u201336. https:\/\/doi.org\/10.1146\/annurev.biophys.37.032807.125908.","journal-title":"Annu Rev Biophys"},{"issue":"7","key":"14708_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrm.2016.50","volume":"17","author":"CF Bourgeois","year":"2016","unstructured":"Bourgeois CF, Mortreux F, Auboeuf D. The multiple functions of RNA helicases as drivers and regulators of gene expression. Nat Rev Mol Cell Biol. 2016;17(7):426\u201338. https:\/\/doi.org\/10.1038\/nrm.2016.50.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"27","key":"14708_CR11","doi-asserted-by":"publisher","first-page":"42716","DOI":"10.18632\/oncotarget.8446","volume":"7","author":"T Lee","year":"2016","unstructured":"Lee T, Pelletier J. The biology of DHX9 and its potential as a therapeutic target. Oncotarget. 2016;7(27):42716\u201339. https:\/\/doi.org\/10.18632\/oncotarget.8446.","journal-title":"Oncotarget"},{"issue":"1","key":"14708_CR12","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1038\/s41467-018-06677-1","volume":"9","author":"P Chakraborty","year":"2018","unstructured":"Chakraborty P, Huang JTJ, Hiom K. DHX9 helicase promotes R-loop formation in cells with impaired RNA splicing. Nat Commun. 2018;9(1):4346. https:\/\/doi.org\/10.1038\/s41467-018-06677-1.","journal-title":"Nat Commun"},{"issue":"2","key":"14708_CR13","first-page":"674","volume":"9","author":"S Cao","year":"2017","unstructured":"Cao S, Sun R, Wang W, Meng X, Zhang Y, Zhang N, Yang S. RNA helicase DHX9 May be a therapeutic target in lung cancer and inhibited by Enoxacin. Am J Transl Res. 2017;9(2):674\u201382.","journal-title":"Am J Transl Res"},{"issue":"1","key":"14708_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41420-022-01004-6","volume":"8","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Yong H, Cui W, Chu S, Li M, Li Z, Bai J, Zhang H. Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9. Cell Death Discov. 2022;8(1):192. https:\/\/doi.org\/10.1038\/s41420-022-01004-6.","journal-title":"Cell Death Discov"},{"issue":"24","key":"14708_CR15","doi-asserted-by":"publisher","first-page":"8261","DOI":"10.1007\/s00018-021-04013-3","volume":"78","author":"S Liu","year":"2021","unstructured":"Liu S, He L, Wu J, Wu X, Xie L, Dai W, Chen L, Xie F, Liu Z. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-kappaB signaling pathway. Cell Mol Life Sci. 2021;78(24):8261\u201381. https:\/\/doi.org\/10.1007\/s00018-021-04013-3.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"14708_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-021-01857-2","volume":"40","author":"P Hou","year":"2021","unstructured":"Hou P, Meng S, Li M, Lin T, Chu S, Li Z, Zheng J, Gu Y, Bai J. LINC00460\/DHX9\/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. J Exp Clin Cancer Res. 2021;40(1):52. https:\/\/doi.org\/10.1186\/s13046-021-01857-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"14708_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13046-022-02384-4","volume":"41","author":"L Chellini","year":"2022","unstructured":"Chellini L, Pieraccioli M, Sette C, Paronetto MP. The DNA\/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer. J Exp Clin Cancer Res. 2022;41(1):178. https:\/\/doi.org\/10.1186\/s13046-022-02384-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"14708_CR18","doi-asserted-by":"publisher","first-page":"1066717","DOI":"10.3389\/fonc.2022.1066717","volume":"12","author":"LG Chen","year":"2022","unstructured":"Chen LG, Cui Y, Lu WQ, Wu H, Jiang JS, Ding KF. The enigmatic helicase DHX9 as a candidate prognostic biomarker for resected pancreatic ductal adenocarcinoma. Front Oncol. 2022;12:1066717. https:\/\/doi.org\/10.3389\/fonc.2022.1066717.","journal-title":"Front Oncol"},{"issue":"4","key":"14708_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.5114\/aoms.2019.85204","volume":"15","author":"JZ Zhou","year":"2019","unstructured":"Zhou JZ, Hu MR, Diao HL, Wang QW, Huang Q, Ge BJ. Comprehensive analysis of differentially expressed circrnas revealed a CeRNA network in pancreatic ductaladenocarcinoma. Arch Med Sci. 2019;15(4):979\u201391. https:\/\/doi.org\/10.5114\/aoms.2019.85204.","journal-title":"Arch Med Sci"},{"issue":"6","key":"14708_CR20","doi-asserted-by":"publisher","first-page":"106962","DOI":"10.1016\/j.isci.2023.106962","volume":"26","author":"N Huang","year":"2023","unstructured":"Huang N, Song Y, Shi W, Guo J, Zhang Z, He Q, Wu L, Li X, Xu F. DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes. iScience. 2023;26(6):106962. https:\/\/doi.org\/10.1016\/j.isci.2023.106962.","journal-title":"iScience"},{"issue":"3","key":"14708_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.gpb.2016.04.002","volume":"14","author":"T Li","year":"2016","unstructured":"Li T, Zhou ZW, Ju Z, Wang ZQ. DNA damage response in hematopoietic stem cell ageing. Genomics Proteom Bioinf. 2016;14(3):147\u201354. https:\/\/doi.org\/10.1016\/j.gpb.2016.04.002.","journal-title":"Genomics Proteom Bioinf"},{"issue":"4","key":"14708_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/carcin\/bgx002","volume":"38","author":"S Biechonski","year":"2017","unstructured":"Biechonski S, Yassin M, Milyavsky M. DNA-damage response in hematopoietic stem cells: an evolutionary trade-off between blood regeneration and leukemia suppression. Carcinogenesis. 2017;38(4):367\u201377. https:\/\/doi.org\/10.1093\/carcin\/bgx002.","journal-title":"Carcinogenesis"},{"key":"14708_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ydbio.2021.03.003","volume":"475","author":"Y Ding","year":"2021","unstructured":"Ding Y, Liu Z, Liu F. Transcriptional and epigenetic control of hematopoietic stem cell fate decisions in vertebrates. Dev Biol. 2021;475:156\u201364. https:\/\/doi.org\/10.1016\/j.ydbio.2021.03.003.","journal-title":"Dev Biol"},{"key":"14708_CR24","doi-asserted-by":"publisher","unstructured":"Lee SY, Miller KM, Kim JJ. Clinical and mechanistic implications of R-Loops in human leukemias. Int J Mol Sci. 2023;24(6). https:\/\/doi.org\/10.3390\/ijms24065966.","DOI":"10.3390\/ijms24065966"},{"issue":"4","key":"14708_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss R, Faraggi D, Reiser B. Estimation of the Youden index and its associated cutoff point. Biom J. 2005;47(4):458\u201372. https:\/\/doi.org\/10.1002\/bimj.200410135.","journal-title":"Biom J"},{"issue":"12","key":"14708_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"14708_CR27","doi-asserted-by":"publisher","unstructured":"The Gene Ontology C. The gene ontology resource: 20 years and still going strong. Nucleic Acids Res. 2019;47(D1). https:\/\/doi.org\/10.1093\/nar\/gky1055. D330-D338.","DOI":"10.1093\/nar\/gky1055"},{"key":"14708_CR28","unstructured":"Daniels M, Duncan H, Sparling KW, Andrew B, Lee Y-T, Castro J, Ribich S, Sickmier E, Allen, Tasker A, Stewart, Mills J, Patent. WO\/2023\/158795. https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2023158795"},{"issue":"4","key":"14708_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1158\/0008-5472.CAN-24-0397","volume":"85","author":"J Castro","year":"2025","unstructured":"Castro J, Daniels MH, Brennan D, Johnston B, Gotur D, Lee YT, Knockenhauer KE, Lu C, Wu J, Nayak S, et al. A potent, selective, Small-Molecule inhibitor of DHX9 abrogates proliferation of microsatellite instable cancers with deficient mismatch repair. Cancer Res. 2025;85(4):758\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0397.","journal-title":"Cancer Res"},{"issue":"6","key":"14708_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11899-017-0418-6","volume":"12","author":"BK Ragon","year":"2017","unstructured":"Ragon BK, DiNardo CD. Targeting IDH1 and IDH2 mutations in acute myeloid leukemia. Curr Hematol Malig Rep. 2017;12(6):537\u201346. https:\/\/doi.org\/10.1007\/s11899-017-0418-6.","journal-title":"Curr Hematol Malig Rep"},{"issue":"5","key":"14708_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41408-021-00495-3","volume":"11","author":"N Daver","year":"2021","unstructured":"Daver N, Venugopal S, Ravandi F. FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm. Blood Cancer J. 2021;11(5):104. https:\/\/doi.org\/10.1038\/s41408-021-00495-3.","journal-title":"Blood Cancer J"},{"issue":"6","key":"14708_CR32","doi-asserted-by":"publisher","first-page":"e912","DOI":"10.1097\/HS9.0000000000000912","volume":"7","author":"AH Wei","year":"2023","unstructured":"Wei AH, Roberts AW. BCL2 inhibition: A new paradigm for the treatment of AML and beyond. Hemasphere. 2023;7(6):e912. https:\/\/doi.org\/10.1097\/HS9.0000000000000912.","journal-title":"Hemasphere"},{"key":"14708_CR33","doi-asserted-by":"publisher","unstructured":"Castro I, Sampaio-Marques B, Ludovico P. Targeting metabolic reprogramming in acute myeloid leukemia. Cells. 2019;8(9). https:\/\/doi.org\/10.3390\/cells8090967.","DOI":"10.3390\/cells8090967"},{"issue":"3","key":"14708_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O\u2019Dwyer KM, et al. BCL-2 Inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12(3):329\u201341. https:\/\/doi.org\/10.1016\/j.stem.2012.12.013.","journal-title":"Cell Stem Cell"},{"key":"14708_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ceb.2017.12.010","volume":"49","author":"HW Snoeck","year":"2017","unstructured":"Snoeck HW. Mitochondrial regulation of hematopoietic stem cells. Curr Opin Cell Biol. 2017;49:91\u20138. https:\/\/doi.org\/10.1016\/j.ceb.2017.12.010.","journal-title":"Curr Opin Cell Biol"},{"issue":"4","key":"14708_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2020.10.001","volume":"27","author":"R Culp-Hill","year":"2021","unstructured":"Culp-Hill R, D\u2019Alessandro A, Pietras EM. Extinguishing the embers: targeting AML metabolism. Trends Mol Med. 2021;27(4):332\u201344. https:\/\/doi.org\/10.1016\/j.molmed.2020.10.001.","journal-title":"Trends Mol Med"},{"issue":"5","key":"14708_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, Pei S, Khan N, Adane B, Ye H, et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell. 2018;34(5):724\u2013e740724. https:\/\/doi.org\/10.1016\/j.ccell.2018.10.005.","journal-title":"Cancer Cell"},{"issue":"4","key":"14708_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1182\/blood.2019898114","volume":"134","author":"CL Jones","year":"2019","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Culp-Hill R, Reisz JA, Pei S, Gustafson A, Khan N, DeGregori J, Pollyea DA, et al. Cysteine depletion targets leukemia stem cells through Inhibition of electron transport complex II. Blood. 2019;134(4):389\u201394. https:\/\/doi.org\/10.1182\/blood.2019898114.","journal-title":"Blood"},{"issue":"12","key":"14708_CR39","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, Stevens BM, Jones CL, Winters A, Pei S, Minhajuddin M, D\u2019Alessandro A, Culp-Hill R, Riemondy KA, Gillen AE, et al. Venetoclax with Azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia. Nat Med. 2018;24(12):1859\u201366. https:\/\/doi.org\/10.1038\/s41591-018-0233-1.","journal-title":"Nat Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14708-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14708-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14708-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:29:56Z","timestamp":1759274996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14708-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14708"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14708-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Affiliated Hospital of USTC (Approval No. 2023-RE-307) and informed consent was obtained from all patients. None of the patients\u2019 names or other personal information was disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Correspondence to Huaiping Zhu.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Corresponding authors"}}],"article-number":"1464"}}